Company Overview

MPX International Corporation (OTC: MPXOF) was a Canadian-based cannabis company focused on the production, distribution, and marketing of medical and wellness-oriented cannabis products. The company operated primarily in the regulated cannabis and cannabinoid consumer products industries, with activities spanning cultivation, extraction, branded product development, and international distribution. Public disclosures and market filings indicate that MPX International pursued opportunities in both medical cannabis and cannabidiol (CBD) wellness categories, particularly in Europe and Canada.

The company’s primary revenue drivers were associated with cannabis cultivation, cannabis-derived consumer products, and international distribution arrangements. MPX International positioned itself around cross-border cannabis market expansion, especially in jurisdictions with evolving medical cannabis regulations. Its historical development included the acquisition and development of cultivation and production assets, as well as expansion into European markets through subsidiaries and strategic investments. Available public records indicate the company sought to establish an international platform rather than operate solely as a domestic Canadian producer. Some operational and financial details became less consistently reported in later periods, and certain historical disclosures are incomplete across public sources.

Business Operations

MPX International conducted operations through cannabis cultivation, extraction, manufacturing, and distribution businesses. Its operations included licensed cannabis production assets and international distribution channels focused on medical cannabis and CBD products. The company’s business structure included subsidiaries and operating entities tied to cultivation and pharmaceutical-style distribution activities. Public filings referenced activities in both Canadian and European cannabis markets, including product supply and brand development initiatives.

The company’s operational footprint included interests connected to Switzerland and other European jurisdictions where medical cannabis frameworks were developing. MPX International also pursued relationships with distributors, pharmacies, and regulated cannabis supply channels. Reported assets included cultivation infrastructure and cannabis processing capabilities intended to support both domestic production and export-oriented opportunities. Data regarding the long-term operational status of certain subsidiaries and facilities is inconclusive based on available public sources.

Strategic Position & Investments

MPX International’s strategic direction centered on international cannabis expansion, with a particular emphasis on European medical cannabis opportunities and CBD wellness markets. The company pursued acquisitions and investments intended to provide cultivation capacity, product manufacturing, and regional market access. Public disclosures referenced investments in European cannabis operations and efforts to establish vertically integrated capabilities spanning production through distribution.

The company was associated with subsidiaries and investments tied to regulated cannabis production and international commercialization efforts. Strategic positioning appeared focused on entering markets with emerging medical cannabis regulations rather than competing solely in the highly saturated Canadian recreational market. Available records also indicate involvement in cannabinoid wellness products and pharmaceutical-oriented distribution channels. However, publicly available information regarding the ultimate performance and integration of certain acquisitions and investments remains limited.

Geographic Footprint

MPX International was headquartered in Canada and maintained operational interests across multiple international markets, particularly in Europe. Public disclosures identified activities connected to Switzerland and broader European cannabis distribution opportunities. The company also maintained exposure to the North American cannabis sector through Canadian operations and public market listings.

Its international strategy emphasized jurisdictions with regulated or emerging medical cannabis frameworks. The company sought to leverage cross-border production and distribution relationships to participate in evolving cannabinoid markets outside Canada. While public filings and investor materials referenced international operations and expansion plans, the precise scale of active operations in certain jurisdictions became less transparent in later reporting periods.

Leadership & Governance

MPX International was led by executives with backgrounds in cannabis operations, finance, and international business development. Public company disclosures identified leadership focused on expanding regulated cannabis infrastructure and building international market access. The company’s governance structure followed the standard framework for publicly traded Canadian issuers, with executive leadership overseeing cultivation, finance, compliance, and strategic growth initiatives.

Key executives publicly associated with the company included:

• W. Scott Boyes – Chief Executive Officer
• David C. McAuley – Chairman
• Michael Perron – President and Director

Leadership communications emphasized international expansion, regulatory compliance, and long-term participation in medical cannabis and cannabinoid wellness markets. Some executive and governance information varied across reporting periods, and certain later-stage corporate updates are inconclusive based on available public sources.